METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSING, AND CONFIRMING PREECLAMPSIA
申请人:Cooper, Matthew
公开号:EP3175239A1
公开(公告)日:2017-06-07
COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOMAL DISORDERS AND LEUKODYSTROPHIES
申请人:The Johns Hopkins University
公开号:EP3368088A1
公开(公告)日:2018-09-05
METHODS FOR DETECTION OF PREECLAMPSIA
申请人:Lajoie Gilles Andre
公开号:US20100113286A1
公开(公告)日:2010-05-06
Biomarkers associated with preeclampsia were identified. Nine proteins were identified as being differentially regulated between the control and the under 28-weeks preeclamptic samples. Similarly three proteins were identified as being differentially regulated between the control and the over 28-weeks preeclamptic samples. These 12 proteins can be used as potential biomarkers in the diagnosing and prognosing of preeclampsia.
A SCREENING METHOD FOR CEREBROTENDINOUS XANTHOMATOSIS USING BILE ALCOHOL GLUCURONIDES AND METABOLITE RATIOS
申请人:Academisch Medisch Centrum
公开号:US20210033626A1
公开(公告)日:2021-02-04
The invention relates to a method of diagnosing or screening for 27-hydroxylase (CYP27A1) deficiency in an animal comprising: determining in a biological sample the intensity signal by mass analysis of at least a bile alcohol glucuronide and a C24- or C27-bile acid or a conjugate thereof, comparing the intensity signals to a control sample or control value, and determining 27-hydroxylase (CYP27A1) deficiency based on said comparison.